05:56 PM EDT, 10/09/2025 (MT Newswires) -- William Guyer, Chief Development Officer, on October 07, 2025, sold 20,000 shares in Corcept Therapeutics ( CORT ) for $1,798,782. Following the Form 4 filing with the SEC, Guyer has control over a total of 5,287 common shares of the company, with 5,287 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1088856/000119312525236107/xslF345X05/ownership.xml